Clinical trial Recruiting at 1 site Interventional Ages 40 to 60

Effects of Feldenkrais Exercises on Knee Osteoarthritis

Official title: Effects of Feldenkrais Exercises on Pain, Range of Motion, and Disability in Patients With Knee Osteoarthritis

Run by Riphah International University · NCT06875817 · Data updated 2026-11-12

This study is testing if Feldenkrais exercises can help people with knee osteoarthritis feel less pain and move better compared to regular physical therapy.

More Knee Osteoarthritis (Knee OA) trials

Quick facts

Study typeInterventional
Ages40 Years to 60 Years
SexAll
Enrollment32 (estimated)
SponsorRiphah International University
Academic / other
Drugs / interventionschemotherapy
Locations1 site (Lahore, Punjab Province)
StatusRecruiting
StartedJanuary 2, 2025
Main results expectedSeptember 2, 2025
Study endsSeptember 15, 2025
Registry record updatedMarch 13, 2025
Trial IDNCT06875817 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are individuals aged 40 to 60 years with grade 2 or 3 knee osteoarthritis and significant pain.

Probably not a fit

Patients with severe cognitive impairments, recent knee surgery, or contraindications to physical activity may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to evaluate the impact of Feldenkrais exercises on pain, range of motion, and disability in patients suffering from knee osteoarthritis. Conducted as a randomized controlled trial at RIPHAH Rehabilitation Clinic, it compares the efficacy of Feldenkrais exercises to conventional physical therapy. Participants aged 40-60 years with specific osteoarthritis severity will be recruited and randomly assigned to either the Feldenkrais group or the conventional therapy group. The study will assess improvements in pain levels and functional ability over the course of the intervention.

Why it matters

Potential benefit: If successful, this study could provide a non-invasive treatment option that significantly improves pain management and mobility for knee osteoarthritis patients.

How similar studies have gone: While the Feldenkrais Method has shown promise in other contexts, this specific application for knee osteoarthritis is relatively novel and has not been extensively tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age between 40 to 60 years of patients.
* Both female and male
* Able to walk for 6 minutes (Timed up-and-go test)
* Able to rise from floor
* Grade 2 and 3 of osteoarthritis diagnosed with radiograph (Kellgren and Lawrence classification system)
* Pain reported on VAS score ˃6/10 in knee region for more than 3 months

Exclusion Criteria:

* • Tuberculosis, carcinoma, heart disease, and osteoporosis

  * Any trauma or localized infection in the knee joint
  * Hyper flexibility
  * Open sores
  * Ongoing radiotherapy, chemotherapy, steroid therapy, or anticoagulants
  * Psychiatric diseases such as phobia/obsession and depression
  * Allergy to hot pack
  * Patients with a history of surgery in the knee region within a year.
  * Severe cognitive impairments
  * Contraindications to physical activity
  * Concurrent participation in other physical therapy programs

Where it's running

  • RIPHAH Rehabilitation Clinic, Punjab, Pakistan
    Lahore, Punjab Province, Pakistan
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.